|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gilbertson RJ: Mapping cancer origins.
Cell. 145:25–29. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dhanasekaran R, Deutzmann A,
Mahauad-Fernandez WD, Hansen AS, Gouw AM and Felsher DW: The MYC
oncogene - the grand orchestrator of cancer growth and immune
evasion. Nat Rev Clin Oncol. 19:23–36. 2022. View Article : Google Scholar
|
|
4
|
Huang H, Bhat A, Woodnutt G and Lappe R:
Targeting the ANGPT-TIE2 pathway in malignancy. Nat Rev Cancer.
10:575–585. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Eklund L, Kangas J and Saharinen P:
Angiopoietin-Tie signalling in the cardiovascular and lymphatic
systems. Clin Sci (Lond). 131:87–103. 2017. View Article : Google Scholar
|
|
6
|
Guo L, Li SY, Ji FY, Zhao YF, Zhong Y, Lv
XJ, Wu XL and Qian GS: Role of Angptl4 in vascular permeability and
inflammation. Inflamm Res. 63:13–22. 2014. View Article : Google Scholar
|
|
7
|
Aryal B, Price NL, Suarez Y and
Fernández-Hernando C: ANGPTL4 in Metabolic and Cardiovascular
Disease. Trends Mol Med. 25:723–734. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tan MJ, Teo Z, Sng MK, Zhu P and Tan NS:
Emerging roles of angiopoietin-like 4 in human cancer. Mol Cancer
Res. 10:677–688. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
La Paglia L, Listì A, Caruso S, Amodeo V,
Passiglia F, Bazan V and Fanale D: Potential role of ANGPTL4 in the
cross talk between metabolism and cancer through PPAR signaling
pathway. PPAR Res. 2017:81872352017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kersten S: Angiopoietin-like 3 in
lipoprotein metabolism. Nat Rev Endocrinol. 13:731–739. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sylvers-Davie KL and Davies BSJ:
Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and
ANGPTL8. Am J Physiol Endocrinol Metab. 321:E493–E508. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang J, Song QY, Niu SX, Chen HJ, Petersen
RB, Zhang Y and Huang K: Emerging roles of angiopoietin-like
proteins in inflammation: Mechanisms and potential as
pharmacological targets. J Cell Physiol. 237:98–117. 2022.
View Article : Google Scholar
|
|
13
|
Thorin E, Labbé P, Lambert M, Mury P,
Dagher O, Miquel G and Thorin-Trescases N: Angiopoietin-like
proteins: Cardiovascular biology and therapeutic targeting for the
prevention of cardiovascular diseases. Can J Cardiol. 39:1736–1756.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kersten S: Role and mechanism of the
action of angiopoietin-like protein ANGPTL4 in plasma lipid
metabolism. J Lipid Res. 62:1001502021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zuo Y, He Z, Chen Y and Dai L: Dual role
of ANGPTL4 in inflammation. Inflamm Res. 72:1303–1313. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim I, Kim HG, Kim H, Kim HH, Park SK, Uhm
CS, Lee ZH and Koh GY: Hepatic expression, synthesis and secretion
of a novel fibrinogen/angiopoietin-related protein that prevents
endothelial-cell apoptosis. Biochem J. 346:603–610. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yoon JC, Chickering TW, Rosen ED, Dussault
B, Qin Y, Soukas A, Friedman JM, Holmes WE and Spiegelman BM:
Peroxisome proliferator-activated receptor gamma target gene
encoding a novel angiopoietin-related protein associated with
adipose differentiation. Mol Cell Biol. 20:5343–5349. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kersten S, Mandard S, Tan NS, Escher P,
Metzger D, Chambon P, Gonzalez FJ, Desvergne B and Wahli W:
Characterization of the fasting-induced adipose factor FIAF, a
novel peroxisome proliferator-activated receptor target gene. J
Biol Chem. 275:28488–28493. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Górecka M, Krzemiński K, Buraczewska M,
Kozacz A, Dąbrowski J and Ziemba AW: Effect of mountain
ultra-marathon running on plasma angiopoietin-like protein 4 and
lipid profile in healthy trained men. Eur J Appl Physiol.
120:117–125. 2020. View Article : Google Scholar :
|
|
20
|
Li L, Foo BJW, Kwok KW, Sakamoto N, Mukae
H, Izumikawa K, Mandard S, Quenot JP, Lagrost L, The WK, et al:
Antibody treatment against angiopoietin-like 4 reduces pulmonary
edema and injury in secondary pneumococcal pneumonia. mBio.
10:e024692019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sodhi A, Ma T, Menon D, Deshpande M, Jee
K, Dinabandhu A, Vancel J, Lu D and Montaner S: Angiopoietin-like 4
binds neuropilins and cooperates with VEGF to induce diabetic
macular edema. J Clin Invest. 129:4593–4608. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kersten S, Lichtenstein L, Steenbergen E,
Mudde K, Hendriks HF, Hesselink MK, Schrauwen P and Müller M:
Caloric restriction and exercise increase plasma ANGPTL4 levels in
humans via elevated free fatty acids. Arterioscler Thromb Vasc
Biol. 29:969–974. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Singh AK, Aryal B, Chaube B, Rotllan N,
Varela L, Horvath TL, Suárez Y and Fernández-Hernando C: Brown
adipose tissue derived ANGPTL4 controls glucose and lipid
metabolism and regulates thermogenesis. Mol Metab. 11:59–69. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shu L, Wang C, Ding Z, Tang J, Zhu Y, Wu
L, Wang Z, Zhang T, Wang T, Xu Y and Sun L: A novel regulated
network mediated by downregulation HIF1A-AS2 lncRNA impairs
placental angiogenesis by promoting ANGPTL4 expression in
preeclampsia. Front Cell Dev Biol. 10:8370002022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Spitler KM, Shetty SK, Cushing EM,
Sylvers-Davie KL and Davies BSJ: Chronic high-fat feeding and
prolonged fasting in liver-specific ANGPTL4 knockout mice. Am J
Physiol Endocrinol Metab. 321:E464–E478. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Alex S, Lichtenstein L, Dijk W, Mensink
RP, Tan NS and Kersten S: ANGPTL4 is produced by entero-endocrine
cells in the human intestinal tract. Histochem Cell Biol.
141:383–391. 2014. View Article : Google Scholar
|
|
27
|
Kuo T, Chen TC, Yan S, Foo F, Ching C,
McQueen A and Wang JC: Repression of glucocorticoid-stimulated
angiopoietin-like 4 gene transcription by insulin. J Lipid Res.
55:919–928. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Inoue T, Kohro T, Tanaka T, Kanki Y, Li G,
Poh HM, Mimura I, Kobayashi M, Taguchi A, Maejima T, et al:
Cross-enhancement of ANGPTL4 transcription by HIF1 alpha and PPAR
beta/delta is the result of the conformational proximity of two
response elements. Genome Biol. 15:R632014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kaddatz K, Adhikary T, Finkernagel F,
Meissner W, Müller-Brüsselbach S and Müller R: Transcriptional
profiling identifies functional interactions of TGF β and PPAR β/δ
signaling: Synergistic induction of ANGPTL4 transcription. J Biol
Chem. 285:29469–29479. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhu C, Teng L, Lai Y, Yao X, Fang Y, Wang
Z, Lin S, Zhang H, Li Q, Li Y, et al: Adipose-derived stem cells
promote glycolysis and peritoneal metastasis via
TGF-β1/SMAD3/ANGPTL4 axis in colorectal cancer. Cell Mol Life Sci.
81:1892024. View Article : Google Scholar
|
|
31
|
Gong X, Hou Z, Endsley MP, Gronseth EI,
Rarick KR, Jorns JM, Yang Q, Du Z, Yan K, Bordas ML, et al:
Interaction of tumor cells and astrocytes promotes breast cancer
brain metastases through TGF-β2/ANGPTL4 axes. NPJ Precis Oncol.
3:242019. View Article : Google Scholar
|
|
32
|
Ding S, Lin Z, Zhang X, Jia X, Li H, Fu Y,
Wang X, Zhu G, Lu G, Xiao W and Gong W: Deficiency of
angiopoietin-like 4 enhances CD8(+) T cell bioactivity via
metabolic reprogramming for impairing tumour progression.
Immunology. 170:28–46. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kolb R, Kluz P, Tan ZW, Borcherding N,
Bormann N, Vishwakarma A, Balcziak L, Zhu P, Davies BS, Gourronc F,
et al: Obesity-associated inflammation promotes angiogenesis and
breast cancer via angiopoietin-like 4. Oncogene. 38:2351–2363.
2019. View Article : Google Scholar :
|
|
34
|
Avalle L, Raggi L, Monteleone E, Savino A,
Viavattene D, Statello L, Camperi A, Stabile SA, Salemme V, De
Marzo N, et al: STAT3 induces breast cancer growth via ANGPTL4,
MMP13 and STC1 secretion by cancer associated fibroblasts.
Oncogene. 41:1456–1467. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li YK, Gao AB, Zeng T, Liu D, Zhang QF,
Ran XM, Tang ZZ, Li Y, Liu J, Zhang T, et al: ANGPTL4 accelerates
ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis
in the tumor microenvironment by activating the JAK2/STAT3 pathway
and interacting with ESM1. J Transl Med. 22:462024. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu J, Wu F, Zhu Y, Wu T, Cao T, Gao W, Liu
M, Qian W, Feng G, Xi X and Hou S: ANGPTL4 regulates ovarian cancer
progression by activating the ERK1/2 pathway. Cancer Cell Int.
24:542024. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wu Y, Gao J and Liu X: Deregulation of
angiopoietin-like 4 slows ovarian cancer progression through
vascular endothelial growth factor receptor 2 phosphorylation.
Cancer Cell Int. 21:1712021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wen L, Zhang Y, Yang B, Han F, Ebadi AG
and Toughani M: Knockdown of angiopoietin-like protein 4 suppresses
the development of colorectal cancer. Cell Mol Biol
(Noisy-le-grand). 66:117–124. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen JW, Luo YJ, Yang ZF, Wen LQ and Huang
L: Knockdown of angiopoietin-like 4 inhibits the development of
human gastric cancer. Oncol Rep. 39:1739–1746. 2018.PubMed/NCBI
|
|
40
|
Bai Y, Cui G, Sun X, Wei M, Liu Y, Guo J
and Yang Y: ANGPTL4 stabilizes bone morphogenetic protein 7 through
deubiquitination and promotes HCC proliferation via the SMAD/MAPK
pathway. DNA Cell Biol. 43:395–400. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bai Y, Cui G, Sun X, Wei M, Liu Y, Guo J
and Yang Y: Angiopoietin-related protein 4-Transcript 3 increases
the proliferation, invasion, and migration of hepatocellular
carcinoma cells and inhibits apoptosis. DNA Cell Biol. 43:175–184.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hu Q, Chen S, Li Y, Hu T, Hu J, Wang C,
Yang F, Yang X, Zhou F, Liu Z, et al: ANGPTL4, a direct target of
hsa-miR-133a-3p, accelerates lung adenocarcinoma lipid metabolism,
proliferation and invasion. Aging (Albany NY). 16:8348–8360.
2023.
|
|
43
|
Fang Y, Li X, Cheng H, Zhang L and Hao J:
ANGPTL4 regulates lung adenocarcinoma pyroptosis and apoptosis via
NLRP3\ASC\ Caspase 8 signaling pathway to promote resistance to
gefitinib. J Oncol. 2022:36235702022. View Article : Google Scholar
|
|
44
|
Zhang T, Kastrenopoulou A, Larrouture Q,
Athanasou NA and Knowles HJ: Angiopoietin-like 4 promotes
osteosarcoma cell proliferation and migration and stimulates
osteoclastogenesis. BMC Cancer. 18:5362018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yang L, Wang Y, Sun R, Zhang Y, Fu Y,
Zheng Z, Ji Z and Zhao D: ANGPTL4 promotes the proliferation of
papillary thyroid cancer via AKT pathway. Onco Targets Ther.
13:2299–2309. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Izraely S, Ben-Menachem S, Sagi-Assif O,
Meshel T, Marzese DM, Ohe S, Zubrilov I, Pasmanik-Chor M, Hoon DSB
and Witz IP: ANGPTL4 promotes the progression of cutaneous melanoma
to brain metastasis. Oncotarget. 8:75778–75796. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hsieh HY, Jou YC, Tung CL, Tsai YS, Wang
YH, Chi CL, Lin RI, Hung SK, Chuang YM, Wu SF, et al: Epigenetic
silencing of the dual-role signal mediator, ANGPTL4 in tumor
tissues and its overexpression in the urothelial carcinoma
microenvironment. Oncogene. 37:673–686. 2018. View Article : Google Scholar
|
|
48
|
Hui B, Ji H, Xu Y, Wang J, Ma Z, Zhang C,
Wang K and Zhou Y: RREB1-induced upregulation of the lncRNA
AGAP2-AS1 regulates the proliferation and migration of pancreatic
cancer partly through suppressing ANKRD1 and ANGPTL4. Cell Death
Dis. 10:2072019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lin S, Miao Y, Zheng X, Dong Y, Yang Q,
Yang Q, Du S, Xu J, Zhou S and Yuan T: ANGPTL4 negatively regulates
the progression of osteosarcoma by remodeling branched-chain amino
acid metabolism. Cell Death Discov. 8:2252022. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Qian P, Li J, Zhang X, Li F, Bei S, Li H,
Sun Q and Feng L: LMX1A inhibits C-Myc expression through ANGPTL4
to exert tumor suppressive role in gastric cancer. PLoS One.
14:e02216402019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Jin Z, De U, Tithi TI, Kleberg J, Nataraj
A, Jolley E, Carelock ME, Davies BS, Zhang W and Kolb R: ANGPTL4
suppresses clear cell renal cell carcinoma via inhibition of
lysosomal acid lipase. Cancer Res Commun. 4:2242–2254. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Xu S, Fang Y, Chang L, Bian Y, Wang Y,
Ding J, Wang Y, Zhang Y, Pu J and Wang K: STAT2-induced linc02231
promotes tumorigenesis and angiogenesis through modulation of
hnRNPA1/ANGPTL4 in colorectal cancer. J Gene Med. 25:e35062023.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hübers C, Abdul Pari AA, Grieshober D,
Petkov M, Schmidt A, Messmer T, Heyer CM, Schölch S, Kapel SS,
Gengenbacher N, et al: Primary tumor-derived systemic nANGPTL4
inhibits metastasis. J Exp Med. 220:e202025952023. View Article : Google Scholar
|
|
54
|
Niu Y, Bao L, Chen Y, Wang C, Luo M, Zhang
B, Zhou M, Wang JE, Fang YV, Kumar A, et al: HIF2-induced long
noncoding RNA RAB11B-AS1 promotes hypoxia-mediated angiogenesis and
breast cancer metastasis. Cancer Res. 80:964–975. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Shen CJ, Chang KY, Lin BW, Lin WT, Su CM,
Tsai JP, Liao YH, Hung LY, Chang WC and Chen BK: Oleic acid-induced
NOX4 is dependent on ANGPTL4 expression to promote human colorectal
cancer metastasis. Theranostics. 10:7083–7099. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Shen CJ, Chan RH, Lin BW, Li NC, Huang YH,
Chang WC and Chen BK: Oleic acid-induced metastasis of
KRAS/p53-mutant colorectal cancer relies on concurrent KRAS
activation and IL-8 expression bypassing EGFR activation.
Theranostics. 13:4650–4666. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Bajwa P, Kordylewicz K, Bilecz A, Lastra
RR, Wroblewski K, Rinkevich Y, Lengyel E and Kenny HA:
Cancer-associated mesothelial cell-derived ANGPTL4 and STC1 promote
the early steps of ovarian cancer metastasis. JCI Insight.
8:e1630192023. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Hefni E, Menon D, Ma T, Asiedu EB, Sultan
A, Meiller T, Schneider A, Sodhi A and Montaner S:
Angiopoietin-like 4 induces head and neck squamous cell carcinoma
cell migration through the NRP1/ABL1/PXN pathway. Cell Signal.
108:1106972023. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Hao H, Guo Z, Li Z, Li J, Jiang S, Fu J,
Jiao Y, Deng X, Han S and Li P: Modified Bu-Fei decoction inhibits
lung metastasis via suppressing angiopoietin-like 4. Phytomedicine.
106:1544092022. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Xiao J, Cao S, Wang J, Li P, Cheng Q, Zhou
X, Dong J, Li Y, Zhao X, Xu Z and Yang L: Leptin-mediated
suppression of lipoprotein lipase cleavage enhances lipid uptake
and facilitates lymph node metastasis in gastric cancer. Cancer
Commun (Lond). 44:855–878. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Chiang KH, Shieh JM, Shen CJ, Chang TW, Wu
PT, Hsu JY, Tsai JP, Chang WC and Chen BK: Epidermal growth
factor-induced COX-2 regulates metastasis of head and neck squamous
cell carcinoma through upregulation of angiopoietin-like 4. Cancer
Sci. 111:2004–2015. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Cai YC, Yang H, Wang KF, Chen TH, Jiang WQ
and Shi YX: ANGPTL4 overexpression inhibits tumor cell adhesion and
migration and predicts favorable prognosis of triple-negative
breast cancer. BMC Cancer. 20:8782020. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Zhang K, Zhai Z, Yu S and Tao Y: DNA
methylation mediated down-regulation of ANGPTL4 promotes colorectal
cancer metastasis by activating the ERK pathway. J Cancer.
12:5473–5485. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Jiang F, Wang GJ, Huang P, Chen S, Xiao H,
Zhang L and Zou H: Geiparvarin inhibits OS metastasis through
upregulation of ANGPTL4 expression by inhibiting miRNA-3912-3p
expression. Evid Based Complement Alternat Med.
2022:46636842022.PubMed/NCBI
|
|
65
|
Katanasaka Y, Kodera Y, Kitamura Y,
Morimoto T, Tamura T and Koizumi F: Epidermal growth factor
receptor variant type III markedly accelerates angiogenesis and
tumor growth via inducing c-myc mediated angiopoietin-like 4
expression in malignant glioma. Mol Cancer. 12:312013. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Xiao W, Tan D, Xiong X, Liu J and Xu J:
Large volume collapse observed in the phase transition in cubic
PbCrO3 perovskite. Proc Natl Acad Sci USA. 107:14026–14029. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Hu K, Babapoor-Farrokhran S, Rodrigues M,
Deshpande M, Puchner B, Kashiwabuchi F, Hassan SJ, Asnaghi L, Handa
JT, Merbs S, et al: Hypoxia-inducible factor 1 upregulation of both
VEGF and ANGPTL4 is required to promote the angiogenic phenotype in
uveal melanoma. Oncotarget. 7:7816–7828. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Mo F, Xu Y and Zhang J, Zhu L, Wang C, Chu
X, Pan Y, Bai Y, Shao C and Zhang J: Effects of hypoxia and
radiation-induced exosomes on migration of lung cancer cells and
angiogenesis of umbilical vein endothelial Cells. Radiat Res.
194:71–80. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Chen S, Yang M and Chang S: LncRNA CCAL
Promotes Angiogenesis Through Regulating the MiR-29b/ANGPTL4 Axis
in Osteosarcoma. Cancer Manag Res. 12:10521–10530. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Okochi-Takada E, Hattori N, Tsukamoto T,
Miyamoto K, Ando T, Ito S, Yamamura Y, Wakabayashi M, Nobeyama Y
and Ushijima T: ANGPTL4 is a secreted tumor suppressor that
inhibits angiogenesis. Oncogene. 33:2273–2278. 2014. View Article : Google Scholar
|
|
71
|
Yang YH, Wang Y, Lam KS, Yau MH, Cheng KK,
Zhang J, Zhu W, Wu D and Xu A: Suppression of the Raf/MEK/ERK
signaling cascade and inhibition of angiogenesis by the carboxyl
terminus of angiopoietin-like protein 4. Arterioscler Thromb Vasc
Biol. 28:835–840. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Ng KT, Xu A, Cheng Q, Guo DY, Lim ZX, Sun
CK, Fung JH, Poon RT, Fan ST, Lo CM and Man K: Clinical relevance
and therapeutic potential of angiopoietin-like protein 4 in
hepatocellular carcinoma. Mol Cancer. 13:1962014. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Gong L, Huang D, Shi Y, Liang Z and Bu H:
Regulated cell death in cancer: From pathogenesis to treatment.
Chin Med J (Engl). 136:653–665. 2023. View Article : Google Scholar
|
|
74
|
Galluzzi L, Vitale I, Aaronson SA, Abrams
JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews
DW, et al: Molecular mechanisms of cell death: recommendations of
the Nomenclature Committee on Cell Death 2018. Cell Death Differ.
25:486–541. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Moujalled D, Strasser A and Liddell JR:
Molecular mechanisms of cell death in neurological diseases. Cell
Death Differ. 28:2029–2044. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Liu Y, Ding W, Wang J, Ao X and Xue J:
Non-coding RNA-mediated modulation of ferroptosis in cardiovascular
diseases. Biomed Pharmacother. 164:1149932023. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Kerr JF, Wyllie AH and Currie AR:
Apoptosis: a basic biological phenomenon with wide-ranging
implications in tissue kinetics. Br J Cancer. 26:239–257. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Nuñez G, Benedict MA, Hu Y and Inohara N:
Caspases: the proteases of the apoptotic pathway. Oncogene.
17:3237–3245. 1998. View Article : Google Scholar
|
|
79
|
Saraste A and Pulkki K: Morphologic and
biochemical hallmarks of apoptosis. Cardiovasc Res. 45:528–537.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Lim MMK, Wee JWK, Soong JC, Chua D, Tan
WR, Lizwan M, Li Y, Teo Z, Goh WWB, Zhu P and Tan NS: Targeting
metabolic flexibility via angiopoietin-like 4 protein sensitizes
metastatic cancer cells to chemotherapy drugs. Mol Cancer.
17:1522018. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Bai Y, Cui G, Sun X, Wei M, Liu Y, Guo J
and Yang Y: Effect of deletion of ANGPTL4 gene on viability,
migration and invasion ability and apoptosis of hepatocellular
carcinoma cells. Discov Med. 36:173–181. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Li X, Chen T, Shi Q, Li J, Cai S, Zhou P,
Zhong Y and Yao L: Angiopoietin-like 4 enhances metastasis and
inhibits apoptosis via inducing bone morphogenetic protein 7 in
colorectal cancer cells. Biochem Biophys Res Commun. 467:128–134.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Hsieh HY, Shen CH, Lin RI, Feng YM, Huang
SY, Wang YH, Wu SF, Hsu CD and Chan MW: Cyproheptadine exhibits
antitumor activity in urothelial carcinoma cells by targeting GSK3β
to suppress mTOR and β-catenin signaling pathways. Cancer Lett.
370:56–65. 2016. View Article : Google Scholar
|
|
84
|
Sattari Fard F, Jalilzadeh N, Mehdizadeh
A, Sajjadian F and Velaei K: Understanding and targeting anoikis in
metastasis for cancer therapies. Cell Biol Int. 47:683–698. 2023.
View Article : Google Scholar
|
|
85
|
Yuan Z, Li Y, Zhang S, Wang X, Dou H, Yu
X, Zhang Z, Yang S and Xiao M: Extracellular matrix remodeling in
tumor progression and immune escape: From mechanisms to treatments.
Mol Cancer. 22:482023. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Chaojun L, Pengping L, Yanjun L, Fangyuan
Z, Yaning H, Yingbo S, Qi C and Hui L: TJP3 promotes T cell
immunity escape and chemoresistance in breast cancer: A
comprehensive analysis of anoikis-based prognosis prediction and
drug sensitivity stratification. Aging (Albany NY). 15:12890–12906.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Liao YH, Chiang KH, Shieh JM, Huang CR,
Shen CJ, Huang WC and Chen BK: Epidermal growth factor-induced
ANGPTL4 enhances anoikis resistance and tumour metastasis in head
and neck squamous cell carcinoma. Oncogene. 36:2228–2242. 2017.
View Article : Google Scholar :
|
|
88
|
Shen CJ, Chan SH, Lee CT, Huang WC, Tsai
JP and Chen BK: Oleic acid-induced ANGPTL4 enhances head and neck
squamous cell carcinoma anoikis resistance and metastasis via
up-regulation of fibronectin. Cancer Lett. 386:110–122. 2017.
View Article : Google Scholar
|
|
89
|
Zhu P, Tan MJ, Huang RL, Tan CK, Chong HC,
Pal M, Lam CR, Boukamp P, Pan JY, Tan SH, et al: Angiopoietin-like
4 protein elevates the prosurvival intracellular O2(-):H2O2 ratio
and confers anoikis resistance to tumors. Cancer Cell. 19:401–415.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Baba K, Kitajima Y, Miyake S, Nakamura J,
Wakiyama K, Sato H, Okuyama K, Kitagawa H, Tanaka T, Hiraki M, et
al: Hypoxia-induced ANGPTL4 sustains tumour growth and anoikis
resistance through different mechanisms in scirrhous gastric cancer
cell lines. Sci Rep. 7:111272017. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
San TT, Khaenam P, Prachayasittikul V,
Sripa B, Kunkeaw N and Chan-On W: Curcumin enhances
chemotherapeutic effects and suppresses ANGPTL4 in
anoikis-resistant cholangiocarcinoma cells. Heliyon. 6:e032552020.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Zhang Z, Cao L, Li J, Liang X, Liu Y, Liu
H, Du J, Qu Z, Cui M, Liu S, et al: Acquisition of anoikis
resistance reveals a synoikis-like survival style in BEL7402
hepatoma cells. Cancer Lett. 267:106–115. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Ness C, Garred Ø, Eide NA, Kumar T, Olstad
OK, Bærland TP, Petrovski G, Moe MC and Noer A: Multicellular tumor
spheroids of human uveal melanoma induce genes associated with
anoikis resistance, lipogenesis, and SSXs. Mol Vis. 23:680–694.
2017.PubMed/NCBI
|
|
94
|
Stockwell BR, Friedmann Angeli JP, Bayir
H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK,
Kagan VE, et al: Ferroptosis: A regulated cell death nexus linking
metabolism, redox biology, and disease. Cell. 171:273–285. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Agmon E, Solon J, Bassereau P and
Stockwell BR: Modeling the effects of lipid peroxidation during
ferroptosis on membrane properties. Sci Rep. 8:51552018. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Tang D and Kroemer G: Ferroptosis. Curr
Biol. 30:R1292–R1297. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Tang D, Chen X, Kang R and Kroemer G:
Ferroptosis: Molecular mechanisms and health implications. Cell
Res. 31:107–125. 2021. View Article : Google Scholar :
|
|
98
|
Li D and Li Y: The interaction between
ferroptosis and lipid metabolism in cancer. Signal Transduct Target
Ther. 5:1082020. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Pope LE and Dixon SJ: Regulation of
ferroptosis by lipid metabolism. Trends Cell Biol. 33:1077–1087.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Jiang X, Stockwell BR and Conrad M:
Ferroptosis: Mechanisms, biology and role in disease. Nat Rev Mol
Cell Biol. 22:266–282. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Zhang Y, Liu X, Zeng L, Zhao X, Chen Q,
Pan Y, Bai Y, Shao C and Zhang J: Exosomal protein
angiopoietin-like 4 mediated radioresistance of lung cancer by
inhibiting ferroptosis under hypoxic microenvironment. Br J Cancer.
127:1760–1772. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Yang WH, Huang Z, Wu J, Ding CC, Murphy SK
and Chi JT: A TAZ-ANGPTL4-NOX2 axis regulates ferroptotic cell
death and chemoresistance in epithelial ovarian cancer. Mol Cancer
Res. 18:79–90. 2020. View Article : Google Scholar :
|
|
103
|
Broz P, Pelegrín P and Shao F: The
gasdermins, a protein family executing cell death and inflammation.
Nat Rev Immunol. 20:143–157. 2020. View Article : Google Scholar
|
|
104
|
Wei X, Xie F, Zhou X, Wu Y, Yan H, Liu T,
Huang J, Wang F, Zhou F and Zhang L: Role of pyroptosis in
inflammation and cancer. Cell Mol Immunol. 19:971–992. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Strowig T, Henao-Mejia J, Elinav E and
Flavell R: Inflammasomes in health and disease. Nature.
481:278–286. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Fang Y, Tian S, Pan Y, Li W, Wang Q, Tang
Y, Yu T, Wu X, Shi Y, Ma P and Shu Y: Pyroptosis: A new frontier in
cancer. Biomed Pharmacother. 121:1095952020. View Article : Google Scholar
|
|
107
|
Man SM, Karki R and Kanneganti TD:
Molecular mechanisms and functions of pyroptosis, inflammatory
caspases and inflammasomes in infectious diseases. Immunol Rev.
277:61–75. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Shi J, Zhao Y, Wang K, Shi X, Wang Y,
Huang H, Zhuang Y, Cai T, Wang F and Shao F: Cleavage of GSDMD by
inflammatory caspases determines pyroptotic cell death. Nature.
526:660–665. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Huang Y, Xu W and Zhou R: NLRP3
inflammasome activation and cell death. Cell Mol Immunol.
18:2114–2127. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Sharma BR and Kanneganti TD: NLRP3
inflammasome in cancer and metabolic diseases. Nat Immunol.
22:550–559. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Sun B, Bai L, Li Q, Sun Y, Li M, Wang J,
Shi X and Zhao M: Knockdown of angiopoietin-like 4 suppresses
sepsis-induced acute lung injury by blocking the NF-κB pathway
activation and hindering macrophage M1 polarization and pyroptosis.
Toxicol In Vitro. 94:1057092024. View Article : Google Scholar
|
|
112
|
DeBerardinis RJ, Lum JJ, Hatzivassiliou G
and Thompson CB: The biology of cancer: metabolic reprogramming
fuels cell growth and proliferation. Cell Metab. 7:11–20. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Kaelin WG Jr and Thompson CB: Q&A:
Cancer: Clues from cell metabolism. Nature. 465:562–564. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Martínez-Reyes I and Chandel NS: Cancer
metabolism: Looking forward. Nat Rev Cancer. 21:669–680. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Xia L, Oyang L, Lin J, Tan S, Han Y, Wu N,
Yi P, Tang L, Pan Q, Rao S, et al: The cancer metabolic
reprogramming and immune response. Mol Cancer. 20:282021.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Pan C, Li B and Simon MC: Moonlighting
functions of metabolic enzymes and metabolites in cancer. Mol Cell.
81:3760–3774. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Hsu PP and Sabatini DM: Cancer cell
metabolism: Warburg and beyond. Cell. 134:703–707. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Fendt SM: 100 years of the Warburg effect:
A cancer metabolism endeavor. Cell. 187:3824–3828. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Paul S, Ghosh S and Kumar S: Tumor
glycolysis, an essential sweet tooth of tumor cells. Semin Cancer
Biol. 86(Pt 3): 1216–1230. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Zheng X, Liu R, Zhou C, Yu H, Luo W, Zhu
J, Liu J, Zhang Z, Xie N, Peng X, et al: ANGPTL4-mediated promotion
of glycolysis facilitates the colonization of fusobacterium
nucleatum in colorectal cancer. Cancer Res. 81:6157–6170. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Mizuno S, Seishima R, Yamasaki J, Hattori
K, Ogiri M, Matsui S, Shigeta K, Okabayashi K, Nagano O, Li L and
Kitagawa Y: Angiopoietin-like 4 promotes glucose metabolism by
regulating glucose transporter expression in colorectal cancer. J
Cancer Res Clin Oncol. 148:1351–1361. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Hanahan D: Hallmarks of cancer: New
dimensions. Cancer Discov. 12:31–46. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Currie E, Schulze A, Zechner R, Walther TC
and Farese RV Jr: Cellular fatty acid metabolism and cancer. Cell
Metab. 18:153–161. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Jin Z, Chai YD and Hu S: Fatty acid
metabolism and cancer. Adv Exp Med Biol. 1280:231–241. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Lee JY, Nam M, Son HY, Hyun K, Jang SY,
Kim JW, Kim MW, Jung Y, Jang E, Yoon SJ, et al: Polyunsaturated
fatty acid biosynthesis pathway determines ferroptosis sensitivity
in gastric cancer. Proc Natl Acad Sci USA. 117:32433–32442. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Pham DV and Park PH: Adiponectin triggers
breast cancer cell death via fatty acid metabolic reprogramming. J
Exp Clin Cancer Res. 41:92022. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Dijk W and Kersten S: Regulation of
lipoprotein lipase by Angptl4. Trends Endocrinol Metab. 25:146–155.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Georgiadi A, Lichtenstein L, Degenhardt T,
Boekschoten MV, van Bilsen M, Desvergne B, Müller M and Kersten S:
Induction of cardiac Angptl4 by dietary fatty acids is mediated by
peroxisome proliferator-activated receptor beta/delta and protects
against fatty acid-induced oxidative stress. Circ Res.
106:1712–1721. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Zhang R and Zhang K: An updated
ANGPTL3-4-8 model as a mechanism of triglyceride partitioning
between fat and oxidative tissues. Prog Lipid Res. 85:1011402022.
View Article : Google Scholar :
|
|
131
|
Lichtenstein L, Mattijssen F, de Wit NJ,
Georgiadi A, Hooiveld GJ, van der Meer R, He Y, Qi L, Köster A,
Tamsma JT, et al: Angptl4 protects against severe proinflammatory
effects of saturated fat by inhibiting fatty acid uptake into
mesenteric lymph node macrophages. Cell Metab. 12:580–592. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Xiao S, Nai-Dong W, Jin-Xiang Y, Long T,
Xiu-Rong L, Hong G, Jie-Cheng Y and Fei Z: ANGPTL4 regulate
glutamine metabolism and fatty acid oxidation in nonsmall cell lung
cancer cells. J Cell Mol Med. 26:1876–1885. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Blücher C, Iberl S, Schwagarus N, Müller
S, Liebisch G, Höring M, Hidrobo MS, Ecker J, Spindler N, Dietrich
A, et al: Secreted factors from adipose tissue reprogram tumor
lipid metabolism and induce motility by modulating PPARα/ANGPTL4
and FAK. Mol Cancer Res. 18:1849–1862. 2020. View Article : Google Scholar
|
|
134
|
Cai Z, Li Y, Ma M, Wang L, Wang H, Liu M
and Jiang C: Adipocytes promote pancreatic cancer migration and
invasion through fatty acid metabolic reprogramming. Oncol Rep.
50:1412023. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Lieu EL, Nguyen T, Rhyne S and Kim J:
Amino acids in cancer. Exp Mol Med. 52:15–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Lippert TH, Ruoff HJ and Volm M: Intrinsic
and acquired drug resistance in malignant tumors. The main reason
for therapeutic failure. Arzneimittelforschung. 58:261–264.
2008.PubMed/NCBI
|
|
137
|
Olivares-Urbano MA, Griñán-Lisón C,
Marchal JA and Núñez MI: CSC Radioresistance: A therapeutic
challenge to improve radiotherapy effectiveness in cancer. Cells.
9:16512020. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Fekir K, Dubois-Pot-Schneider H, Désert R,
Daniel Y, Glaise D, Rauch C, Morel F, Fromenty B, Musso O, Cabillic
F and Corlu A: Retrodifferentiation of Human Tumor Hepatocytes to
Stem Cells Leads to Metabolic Reprogramming and Chemoresistance.
Cancer Res. 79:1869–1883. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Li C, Wang Q, Luo Y and Xiang J: TAZ
regulates the cisplatin resistance of epithelial ovarian cancer
cells via the ANGPTL4/SOX2 axis. Anal Cell Pathol (Amst).
2022:56321642022.PubMed/NCBI
|
|
140
|
Zhou S, Wang R and Xiao H: Adipocytes
induce the resistance of ovarian cancer to carboplatin through
ANGPTL4. Oncol Rep. 44:927–938. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Tsai YT, Wu AC, Yang WB, Kao TJ, Chuang
JY, Chang WC and Hsu TI: ANGPTL4 induces TMZ resistance of
glioblastoma by promoting cancer stemness enrichment via the
EGFR/AKT/4E-BP1 cascade. Int J Mol Sci. 20:56252019. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Gordon ER, Wright CA, James M and Cooper
SJ: Transcriptomic and functional analysis of ANGPTL4
overexpression in pancreatic cancer nominates targets that reverse
chemoresistance. BMC Cancer. 23:5242023. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Li H, Ge C, Zhao F, Yan M, Hu C, Jia D,
Tian H, Zhu M, Chen T, Jiang G, et al: Hypoxia-inducible factor 1
alpha-activated angiopoietin-like protein 4 contributes to tumor
metastasis via vascular cell adhesion molecule-1/integrin β1
signaling in human hepatocellular carcinoma. Hepatology.
54:910–919. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Adhikary T, Brandt DT, Kaddatz K, Stockert
J, Naruhn S, Meissner W, Finkernagel F, Obert J, Lieber S, Scharfe
M, et al: Inverse PPARβ/δ agonists suppress oncogenic signaling to
the ANGPTL4 gene and inhibit cancer cell invasion. Oncogene.
32:5241–5252. 2013. View Article : Google Scholar
|
|
145
|
Tian L, Zhou J, Casimiro MC, Liang B,
Ojeifo JO, Wang M, Hyslop T, Wang C and Pestell RG: Activating
peroxisome proliferator-activated receptor gamma mutant promotes
tumor growth in vivo by enhancing angiogenesis. Cancer Res.
69:9236–9244. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Kim SH, Park YY, Kim SW, Lee JS, Wang D
and DuBois RN: ANGPTL4 induction by prostaglandin E2 under hypoxic
conditions promotes colorectal cancer progression. Cancer Res.
71:7010–7020. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Fresno Vara JA, Casado E, de Castro J,
Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling
pathway and cancer. Cancer Treat Rev. 30:193–204. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Pitt JM, Marabelle A, Eggermont A, Soria
JC, Kroemer G and Zitvogel L: Targeting the tumor microenvironment:
Removing obstruction to anticancer immune responses and
immunotherapy. Ann Oncol. 27:1482–1492. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Zhou S, Tu J, Ding S, Lu G, Lin Z, Ding Y,
Deng B, Zhang Y, Xiao W and Gong W: High expression of
angiopoietin-like protein 4 in advanced colorectal cancer and its
association with regulatory T Cells and M2 macrophages. Pathol
Oncol Res. 26:1269–1278. 2020. View Article : Google Scholar
|
|
150
|
Long F, Wang W, Li S, Wang B, Hu X, Wang
J, Xu Y, Liu M, Zhou J, Si H, et al: The potential crosstalk
between tumor and plasma cells and its association with clinical
outcome and immunotherapy response in bladder cancer. J Transl Med.
21:2982023. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Li F and Ding J: Sialylation is involved
in cell fate decision during development, reprogramming and cancer
progression. Protein Cell. 10:550–565. 2019. View Article : Google Scholar :
|
|
152
|
Ma X, Li M, Wang X, Qi G, Wei L and Zhang
D: Sialylation in the gut: From mucosal protection to disease
pathogenesis. Carbohydr Polym. 343:1224712024. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Calabrese V, Zirino F, Vienna FG, Siligato
R, Cernaro V and Santoro D: Insight into the role of
angiopoietin-like protein 4 in podocypopathies (Review). World Acad
Sci J. 6:292024. View Article : Google Scholar
|
|
154
|
Chugh SS and Clement LC: 'Idiopathic'
minimal change nephrotic syndrome: A podocyte mystery nears the
end. Am J Physiol Renal Physiol. 325:F685–F694. 2023. View Article : Google Scholar
|
|
155
|
Smith BAH, Deutzmann A, Correa KM,
Delaveris CS, Dhanasekaran R, Dove CG, Sullivan DK, Wisnovsky S,
Stark JC, Pluvinage JV, et al: MYC-driven synthesis of siglec
ligands is a glycoimmune checkpoint. Proc Natl Acad Sci USA.
120:e22153761202023. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Stanczak MA and Läubli H: Siglec receptors
as new immune checkpoints in cancer. Mol Aspects Med.
90:1011122023. View Article : Google Scholar
|
|
157
|
Zhao J, Liu J, Wu N, Zhang H, Zhang S, Li
L and Wang M: ANGPTL4 overexpression is associated with progression
and poor prognosis in breast cancer. Oncol Lett. 20:2499–2505.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Nie D, Zheng Q, Liu L, Mao X and Li Z:
Up-regulated of angiopoietin-like protein 4 predicts poor prognosis
in cervical cancer. J Cancer. 10:1896–1901. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Aung TM, Ciin MN, Silsirivanit A, Jusakul
A, Lert-Itthiporn W, Proungvitaya T, Roytrakul S and Proungvitaya
S: Serum angiopoietin-like protein 4: A potential prognostic
biomarker for prediction of vascular invasion and lymph node
metastasis in cholangiocarcinoma patients. Front Public Health.
10:8369852022. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Wang FT, Li XP, Pan MS, Hassan M, Sun W
and Fan YZ: Identification of the prognostic value of elevated
ANGPTL4 expression in gallbladder cancer-associated fibroblasts.
Cancer Med. 10:6035–6047. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Shibata K, Nakayama T, Hirakawa H, Hidaka
S and Nagayasu T: Clinicopathological significance of
angiopoietin-like protein 4 expression in oesophageal squamous cell
carcinoma. J Clin Pathol. 63:1054–1058. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Tanaka T, Imamura T, Irie A, Yoneda M,
Imamura R, Kikuchi K, Kitagawa S, Kubo T, Ogi H and Nakayama H:
Association of high cellular expression and plasma concentration of
angiopoietin-like 4 with tongue cancer lung metastasis and poor
prognosis. Oncol Lett. 24:2992022. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Dong D, Jia L, Zhou Y, Ren L, Li J and
Zhang J: Serum level of ANGPTL4 as a potential biomarker in renal
cell carcinoma. Urol Oncol. 35:279–285. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Kubo H, Kitajima Y, Kai K, Nakamura J,
Miyake S, Yanagihara K, Morito K, Tanaka T, Shida M and Noshiro H:
Regulation and clinical significance of the hypoxia-induced
expression of ANGPTL4 in gastric cancer. Oncol Lett. 11:1026–1034.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Sukonina V, Lookene A, Olivecrona T and
Olivecrona G: Angiopoietin-like protein 4 converts lipoprotein
lipase to inactive monomers and modulates lipase activity in
adipose tissue. Proc Natl Acad Sci USA. 103:17450–17455. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Mysling S, Kristensen KK, Larsson M,
Kovrov O, Bensadouen A, Jørgensen TJ, Olivecrona G, Young SG and
Ploug M: The angiopoietin-like protein ANGPTL4 catalyzes unfolding
of the hydrolase domain in lipoprotein lipase and the endothelial
membrane protein GPIHBP1 counteracts this unfolding. Elife.
5:e209582016. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Yoshida K, Shimizugawa T, Ono M and
Furukawa H: Angiopoietin-like protein 4 is a potent
hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein
lipase. J Lipid Res. 43:1770–1772. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Dijk W, Beigneux AP, Larsson M, Bensadoun
A, Young SG and Kersten S: Angiopoietin-like 4 promotes
intracellular degradation of lipoprotein lipase in adipocytes. J
Lipid Res. 57:1670–1683. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Reimund M, Kovrov O, Olivecrona G and
Lookene A: Lipoprotein lipase activity and interactions studied in
human plasma by isothermal titration calorimetry. J Lipid Res.
58:279–288. 2017. View Article : Google Scholar :
|
|
170
|
Kersten S: New insights into
angiopoietin-like proteins in lipid metabolism and cardiovascular
disease risk. Curr Opin Lipidol. 30:205–211. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Huang RL, Teo Z, Chong HC, Zhu P, Tan MJ,
Tan CK, Lam CR, Sng MK, Leong DT, Tan SM, et al: ANGPTL4 modulates
vascular junction integrity by integrin signaling and disruption of
intercellular VE-cadherin and claudin-5 clusters. Blood.
118:3990–4002. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Cazes A, Galaup A, Chomel C, Bignon M,
Bréchot N, Le Jan S, Weber H, Corvol P, Muller L, Germain S and
Monnot C: Extracellular matrix-bound angiopoietin-like 4 inhibits
endothelial cell adhesion, migration, and sprouting and alters
actin cytoskeleton. Circ Res. 99:1207–1215. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Sheridan C: Amgen's angiopoietin blocker
fails in ovarian cancer. Nat Biotechnol. 33:5–6. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Padua D, Zhang XH, Wang Q, Nadal C, Gerald
WL, Gomis RR and Massagué J: TGFbeta primes breast tumors for lung
metastasis seeding through angiopoietin-like 4. Cell. 133:66–77.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Simeon J, Thrush J and Bailey TA:
Angiopoietin-like protein 4 is a chromatin-bound protein that
enhances mammosphere formation in vitro and experimental
triple-negative breast cancer brain and liver metastases in vivo. J
Carcinog. 20:82021. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Nakayama T, Hirakawa H, Shibata K, Nazneen
A, Abe K, Nagayasu T and Taguchi T: Expression of angiopoietin-like
4 (ANGPTL4) in human colorectal cancer: ANGPTL4 promotes venous
invasion and distant metastasis. Oncol Rep. 25:929–935. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Yi J, Pan BZ, Xiong L and Song HZ:
Clinical significance of angiopoietin-like protein 4 expression in
tissue and serum of esophageal squamous cell carcinoma patients.
Med Oncol. 30:6802013. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Nakayama T, Hirakawa H, Shibata K, Abe K,
Nagayasu T and Taguchi T: Expression of angiopoietin-like 4 in
human gastric cancer: ANGPTL4 promotes venous invasion. Oncol Rep.
24:599–606. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Ma T, Jham BC, Hu J, Friedman ER, Basile
JR, Molinolo A, Sodhi A and Montaner S: Viral G protein-coupled
receptor up-regulates Angiopoietin-like 4 promoting angiogenesis
and vascular permeability in Kaposi's sarcoma. Proc Natl Acad Sci
USA. 107:14363–14368. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Yang W, Khoury E, Guo Q, Prabhu SA, Emond
A, Huang F, Gonçalves C, Zhan Y, Plourde D, Nichol JN, et al: MNK1
signaling induces an ANGPTL4-mediated gene signature to drive
melanoma progression. Oncogene. 39:3650–3665. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Zhu X, Guo X, Wu S and Wei L: ANGPTL4
correlates with NSCLC progression and regulates
epithelial-mesenchymal transition via ERK pathway. Lung.
194:637–646. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Lou H, Lin X, Wei G, Wu Z and Xiao Y:
Construction of an Anoikis-related gene prognostic signature and
identification of ANGPTL4 as a key oncogene in lung adenocarcinoma.
Mol Biotechnol. 66:1290–1302. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Al-Kadash A, Alshaer W, Mahmoud IS,
Wehaibi S and Zihlif M: Enhancing chemosensitivity of PANC1
pancreatic cancer cells to gemcitabine using ANGTPL4, Notch1 and
NF-κβ1 siRNAs. Future Sci OA. 10:FSO9182024. View Article : Google Scholar
|
|
184
|
Hata S, Nomura T, Iwasaki K, Sato R,
Yamasaki M, Sato F and Mimata H: Hypoxia-induced angiopoietin-like
protein 4 as a clinical biomarker and treatment target for human
prostate cancer. Oncol Rep. 38:120–128. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Tanaka T, Imamura T, Yoneda M, Irie A, Ogi
H, Nagata M, Yoshida R, Fukuma D, Kawahara K, Shinohara M and
Nakayama H: Enhancement of active MMP release and invasive activity
of lymph node metastatic tongue cancer cells by elevated signaling
via the TNF-α-TNFR1-NF-κB pathway and a possible involvement of
angiopoietin-like 4 in lung metastasis. Int J Oncol. 49:1377–1384.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Yu Y, Zhang M, Liu J, Xu B, Yang J, Wang
N, Yan S, Wang F, He X, Ji G, et al: Long Non-coding RNA PVT1
promotes cell proliferation and migration by silencing ANGPTL4
expression in cholangiocarcinoma. Mol Ther Nucleic Acids.
13:503–513. 2018. View Article : Google Scholar : PubMed/NCBI
|
